Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ... smdailyjournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from smdailyjournal.com Daily Mail and Mail on Sunday newspapers.
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia GlobeNewswire May 06, 2024 Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found.
Boehringer Ingelheim Shares Positive Results from the First Study Worldwide in Diabetic Macular Ischemia koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.
BI 764524 was well tolerated following intravitreal administration of single and multiple doses in the phase 1/2a trial, with signs pointing to early efficacy.
As AI eye exams prove their worth, lessons for future tech emerge limaohio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from limaohio.com Daily Mail and Mail on Sunday newspapers.